Edition:
Deutschland

Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

1,435JPY
30 Oct 2020
Change (% chg)

¥-26 (-1.81%)
Prev Close
¥1,462
Open
¥1,479
Day's High
¥1,494
Day's Low
¥1,426
Volume
8,821,500
Avg. Vol
4,318,511
52-wk High
¥1,987
52-wk Low
¥1,406

About

Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB... (more)

Buy/Sell

Sell Hold Buy
2.17 Mean rating from 12 analysts

Overall

Beta: 0.75
Market Cap(Mil.): ¥2,671,665.00
Shares Outstanding(Mil.): 1,861.79
Dividend: 21.00
Yield (%): 2.86

Japanese shares slump on virus worries, mixed earnings

TOKYO, Oct 30 Japanese shares fell on Friday and were set for their biggest weekly loss in more than two months as mixed earnings, rising coronavirus cases and uncertainty over the U.S. presidential election hurt sentiment.

Nikkei falls as coronavirus resurgence in Europe hits sentiment

TOKYO, Oct 16 Japan's Nikkei share average fell on Friday as new coronavirus curbs in Europe dimmed hopes of a swift global economic recovery, although losses were limited after Fast Retailing forecast upbeat annual earnings.

Nikkei flat as coronavirus resurgence in Europe hits sentiment

TOKYO, Oct 16 Japan’s Nikkei share average was nearly flat on Friday as new coronavirus curbs in Europe dimmed hopes of a global economic recovery, although gains in Fast Retailing after it forecast upbeat annual earnings helped to cap losses.

Japan shares rise on hopes for U.S. economy, new prime minister eyed

TOKYO, Sept 2 Japanese shares rose on Wednesday after positive data on the U.S. manufacturing sector spurred hopes that a global economic recovery from the COVID-19 pandemic remains on track.

Japan stocks rise on U.S. data, easing concerns about new prime minister

TOKYO, Sept 2 Japanese shares rose on Wednesday after positive data on the U.S. manufacturing sector spurred hopes of a global economic recovery remains on track to bounce back from the COVID-19 pandemic.

Deals of the day-Mergers and acquisitions

Aug 11 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Tuesday: ** British life insurer Prudential said it planned to spin off its U.S. business Jackson to focus on Africa and its largest market Asia, responding to investor pressure for a split.

Photo

Bayer takes on Astellas in purchase of experimental menopause relief

FRANKFURT Bayer moved to acquire a prospective non-hormonal menopause relief for an initial $425 million to strengthen its women's healthcare business, in a challenge to a similar development venture at Astellas .

Photo

Bayer takes on Astellas in purchase of experimental menopause relief

FRANKFURT Bayer moved to acquire a prospective non-hormonal menopause relief for an initial $425 million to strengthen its women's healthcare business, in a challenge to a similar development venture at Astellas .

UPDATE 2-Bayer takes on Astellas in purchase of experimental menopause relief

* Gynaecology unit suffered from litigation, generic competition (Releads, adds rival project, M&A strategy)

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie -0.22%
Rohstoffe -0.82%
Industrie -2.33%
Konjunktur abhängige Waren & Dienstleistungen -0.51%
Konjunktur unabhängige Waren & Dienstleistungen +0.06%
Finanzindustrie -0.79%
Pharma -2.12%
Technologie +0.00%